Labs

BACK TO INDEX

  Liver Function Tests ( Common Blood Tests in Liver Disease)
  Liver Function Tests ;

a breakdown of what an LFT (Liver Function Test) may include, what it does, normal values, and what other than normal values can mean. Also drugs and other things that can affect the results of each test.

Liver function tests: defining what's normal


Your doctor can see how well your liver is working by testing your blood. The most common tests that are used to check how well your liver is working and your biliary system (the tubes that lead out of the liver) are called Liver Function Tests (LFT's). When your liver is working well, the levels are low. When your liver is not working as well as it should, they can become much higher. These substances include chemicals that your liver uses to do its work (called liver enzymes) and bilirubin (pronounced "billy-ru-bin"). Albumin (pronounced "al-byoo-men") is a protein made by the liver.

Your doctor may also order a liver panel, which generally includes the following tests:

ALT/SGPT: Alanine Aminotransferase
AST/SGOT: Aspartate Aminostransferase
AlkP: Alkaline Phosphatase
TBil: Total Bilirubin
DBil: Direct Bilirubin
Q   What does "elevated enzymes of the liver" mean?
A   The answer depends on many things. There are four liver enzymes that are commonly measured:

The ALT, AST, and GGT are transaminases that participate in metabolism. Their elevation suggests damage or inflammation of the liver itself. This occurs in response to infection in the liver or bile ducts (these drain the liver), hepatitis, and reactions to certain drugs and poisons (especially important with tylenol overdose, certain cholesterol lowering drugs, and some mushrooms).

The alkaline phosphatase is another enzyme, and it is predominately elevated when the liver drainage is obstructed. This occurs with gallstones in the bile ducts, and tumors of the liver, bile ducts, and pancreas.

Finally, although not an enzyme, the bilirubin is often measured. Bilirubin is a metabolic end product of decayed red blood cells. It is cleared by the liver. An increased bilirubin is an indicator that the liver, as a whole, is not functioning correctly. Accumulation of this substance in the blood is responsible for the jaundice seen in patients with liver disease

 

                         
 
AFP (Alpha-fetoprotein)
0-8.9 ng/ml
 
Alb (Albumin)
3.3-5.2 mg/dl
 
AlkP (Alkaline phosphatase)
40-125 U/L
 
ALT/SGPT (Alanine Aminotransferase)
7-56 U/L
 
Antibody
 
Anti-HBs (hepatitis B surface antibody)
 
Anti-HBc (hepatitis B core antibody)
Anti-HCV (hepatitis C antibody)
 
Antigen
 
AST/SGOT (Aspartate Aminotransferase)
5-35 U/L
 
Basophils
0.01-0.20 K/µl
 
CBC(Complete Blood Count)
See specific tests RBC HGB WBC and Platelets
 
Cholesterol
100-240 mg/dl
 
CREAT (Creatinine)
0.6-1.4 mg/dl
 
Eosinophils
0.04-0.50 K/µl
 
 
Ferritin
29-300 µg/L
 
Genotype
 
GGT (Gamma-glutamyltranspeptidase)
7-64 U/l
 
Globulin
1-2.8 g/dl
 
HBeAg (hepatitis B e antigen)
 
HBsAg (hepatitis B surface antigen)
 
HCT (Hematocrit)
42-52%
 
Hgb(Hemoglobin)
14-18 g/dl
 
INR (International normalized ratio)
 
Iron

 

LYMPHS(Lymphocytes)
0.8-3.5 K/µl
 
Monocytes
0.2-0.8 K/µl
 
NEUTS (Neutrophils)
2.2-8.6 K/µl
 
 
Platelets
140-400 /mm3
 
Polymerase Chain Reaction (PCR)
 
Protein, total
6.0-8.5 g/dl
 
 
PT (Prothrombin Time)
9.8-13.8 seconds
 
PTT (Partial Thromboplastin Time)
24.2-36.0 seconds
 
Quasispecies
 
RBC(Red Blood Cells)
4.7-6.1 /mm3
 
RIBA™ (recombinant immunoblot assay)
 
 
T3, total
45-137 ng/dl
 
T4, free
9-24 pmol/l
 
TBili (bilirubin, total)
0.1-1.2 mg/dl
 
Triglycerides
10-190 mg/dl
TSH (Thyroid Stimulation Hormone)
0.4-6.0 µIU/ml
WBC(White Blood Cells)
4.8-10.8 /mm3
 
 

                        

 

 

   
 

Liver Function Test
(LFT)

Here is a breakdown of what an LFT (Liver Function Test) may include, what it does, normal values, and what other than normal values can mean. Also drugs and other things that can affect the results of each test.
 

The typical Liver Profile test includes:
 Bilirubin
 Protein
 LDL
 Alkaline Phosphatase
 SGOT/AST (aspartate amino transferase)
 SGPT/ALT (amino alanine transferase)
 Albumin
 Globulin

BLOOD BILIRUBIN:
Test evaluates liver function and the condition of red blood cells. Diagnoses jaundice. Monitors progression of jaundice. Helps confirm diagnosis of obstruction of the bile ducts. Helps diagnose cause of anemia.
Normal Values:
 Adult indirect bilirubin levels--1.1 mg/dl or less
 Adult direct bilirubin levels--Less than 0.5 mg/dl
 Total bilirubin in a newborn--1 to 12mg/dl

bullet What "high" or "increased" may indicate:
 Congenital enzyme deficiencies (Gilbert's disease)
 Liver damage
 Severe hemolytic anemia
 Obstruction of bile ducts from stones or tumors
 If over 20mg/dl in a newborn, exchange transfusion may be needed.

Taking these drugs may affect test results:
Aminophenol, Anti-malarials, Ascorbic acid, Dextran, Epinephrine, Ethoxazene, Histidine, Indican, Isoproterenol, Levodopa, Methyldopa, Novobiocin, Phenazopyridine, Phenelzine, Primaquine, Rifampin, Streptomycin, Sulfa drugs, Theophylline, Tyrosine

BLOOD PROTEIN ELECTROPHORESIS (PROTEIN, ALBUMIN, GLOBULIN):
Purpose of the test is to help confirm blood disorders, gastrointestinal disorders, kidney disorders, liver disease, protein deficiency, diagnosis of tumors.

Normal values:
 Protein--6.6 to 7.9g/dl
 Albumin fraction--3.3 to 4.5g/dl
 Alpha-1-globulin fraction--0.1 to 0.4g/dl
 Alpha-2-globulin ranges--0.5 to 1g/dl
 Beta globulin--0.7to 1.2g/dl
 Gamma globulin--0.5 to 1.6g/dl


What "high" or "increased" may indicate:
 Chronic inflammatory disease
 Chronic syphilis
 Collagen diseases
 Dehydration
 Diabetes mellitus
 Diabetic acidosis
 Early-stage Laennec's cirrhosis
 Fulminating and chronic infections
 Hodgkin's disease
 Monocytic leukemia
 Multiple myeloma
 Rheumatoid arthritis
 Subacute bacterial endocarditis
 Systemic lupus erythematosus
 Tuberculosis
 Vomiting and diarrhea

What "low" or "decreased may indicate:
 Acute cholecystitis
 Benzene and carbon-tetracholoride poisoning
 Blood dyscrasias
 Collagen diseases
 Congestive heart failure
 Diarrhea
 Diabetes mellitus, uncontrolled
 Essential hypertension
 Gastrointestinal disease
 Hemorrhage
 Hepatic disease
 Hepatic dysfunction
 Hodgkin's disease
 Hyperthyroidism
 Hypogammaglobulinemia
 Malabsorption
 Malnutrition
 Metastatic carcinoma
 Neoplastic and renal diseases
 Nephritis
 Nephrosis
 Peptic ulcer
 Plasma loss from burns
 Rheumatoid arthritis
 Sarcoidosis
 Surgical or traumatic shock
 Systemic lupus erythematosus
 Toxemia of pregnancy

Taking these drugs may affect test results:
Cytotoxic agents, Cytotoxin, Cyclosporin

Other factors that may affect test results:
 Pregnancy
 Contrast dyes, such as sulfobromophthalein

BLOOD (SERUM) GLUTAMIC-OXALOACETIC TRANSAMINASE (SGOT)
Purpose of the test:
 Helps diagnose recent severe heart problem
 Helps detect and differentiate between varying forms of liver disease

Normal values:
 Test values are more meaningful when correlated with test results for creatine phosphokinase and lactic dehydrogenase. Values fluctuate and may be transiently and minimally elevated during early phases of heart attack.

 A rising level over several days means continuing damage
 A decreasing level over several days means tissue repair
 8 to 20u/liter
 Normal values for infants are 4 times higher than those of adults

What "high" or "increased" may indicate:
 Acute pancreatitis
 Acute viral hepatitis
 Alcoholic cirrhosis
 Chronic hepatitis
 Delirium tremens
 Dermatomyositis
 Drug-inducted liver injury
 Duchenne muscular dystrophy
 Extensive recent surgery
 Fatty liver
 Hemolytic anemia
 Metastatic hepatic tumor
 Pulmonary embolism
 Severe infectious mononucleosis
 Severe muscle trauma
 Severe myocardial infarction
 Severe passive liver congestion

Taking these drugs may affect test results:
Acetaminophen (large doses), Anti-tubercular agents, Chlorpropamide, Dicumarol, Erythromycin, Methyldopa, Opiates, Pyridoxine, Salicylates, Sulfonamides, Vitamin A

Other factors that may affect test results:
 Strenuous exercise
 Muscle trauma
 Failure to fast overnight

BLOOD GLUTAMIC-PYRUVIC TRANSAMINASE (SGPT)

Purpose of the test:
 Helps detect and evaluate treatment of acute hepatic disease
 Helps distinguish between myocardial and hepatic-tissue damage

Normal values:
 Men--10 to 32 u/liter
 Women--9 to 24u/liter
 Infants--Twice normal range of adults

What "high" or "increased" may indicate:
 Severe hepatitis
 Chronic hepatitis
 Early or improving acute viral hepatitis
 Infectious mononucleosis
 Intrahepatic cholestasis
 Cholecystitis
 Severe hepatic congestion due to heart failure
 Slight to moderately high levels may indicate any condition that produces acute hepatocellular injury.

Taking these drugs may affect test results:
Barbiturates, Chlorpromazine, Codeine, Griseofulvin, Isoniazid, Meperidine, Methyldopa, Morphine, Narcotic analgesics, Nitrofurantoin, Para-aminosalicylic acid, Phenothiazines, Phenytoin, Salicylates, Tetracycline

Other factors that may affect test results:
 Eating lead
 Exposure to carbon tetrachloride
 Failure to fast overnight
 If tourniquet is applied on the arm too long (over 1 minute), it may cause an inaccurate test result. Request another sample to be collected to ensure accuracy.

ALKALINE PHOSPHATASE:
Purpose of test:
 Detects and identifies skeletal disease, especially diseases characterized by rapidly growing bone.
 Detects liver diseases causing obstructions, such as a tumor or abscess.
 Assesses response to vitamin D in treating rickets caused by vitamin-D deficiency.

Normal values:
(Alkaline phosphatase levels measured by chemical inhibition range from):
 Men--90 to 239u/liter
 Women (under age 45)--76 to 196u/liter
 Women (over age 45)--87 to 250u/liter
 Children normally have levels up to 3 times higher than adults

What "high" or "increased" may indicate:
 Acute or complete biliary obstruction
 Deficiency-induced rickets
 Osteomalacia
 Extensive bone metastases
 Hyperparathyroidsm
 Paget's disease

What "low" or "decreased" may indicate:
 Hypophosphatasia
 Protein deficiency
 Magnesium deficiency

Taking these drugs may affect test results:
Albumin, Barbiturates, Chlorpropamide, Halothane, Isoniazid, Methyldopa, Oral contraceptives, Phenothiazines, Phenytoin, Rifampin

Other factors that may affect test results:
 Healing long-bone fractures
 Age (infants, children, adolescents, women over 45)
 Failure to fast overnight
 If tourniquet is applied on the arm too long (over 1 minute), it may cause an inaccurate test result. Request another sample be collected to ensure accuracy.

ANTI-NUCLEAR ANTIBODIES (ANA):
Purpose of test:
 Screens for systemic lupus erythematosus
 Screens for several autoimmune disorders
 Monitors effectiveness of treatment with drugs for systemic lupus erythematosus

Normal values:
 Test for Ana is negative at a titer of 1:32 or below

What absence of ANA may indicate:
 Rules out systemic lupus erythematosus

What low titers may indicate:
 Viral diseases
 Liver disease
 Collagen-vascular disease
 Autoimmune disease

Taking these drugs may affect test results:
Acetazolamide, Aminosalicylic acid (PAS), Chlorothiazide, Chlorpromazine, Chlorprothixene, Clofibrate, Ethosuximide, Gold salts, Griseofulvin, Hydralazine, Isoniazid, Mephenytoin, Methyldopa, Methysergide, Oral contraceptives, Para-aminosaalicylic acid, Penicillin, Phenylbutazone, Phenytoin, Primidone, Procainamide, Propylthiouracil, Wuinidine, Reserpine, Streptomycin, Sulfonamides, Tetracyclines, Thiouracil, Trimethadion

Other factors that may affect test results:
 If tourniquet is applied on the arm for too long (over 1 minute), it may cause an inaccurate test result. Request another sameple to be collected to ensure accuracy.

GAMMA GLUTAMYL TRANSFERASE (GGT):
Purpose of test:
 Provides information about liver disease
 Assesses liver function
 Distinguishes between bone-and-joint disease and liver disease when blood alkaline-phosphatase levels are elevated.

Normal values:
 Men--6 to 37u/liter
 Women under 45--5 to 27u/liter
 Women over 45--6 to 37u/liter

What "high" or "increased" may indicate:
 Acute liver disease
 Acute pancreatitis
 Epilepsy
 Brain tumor
 Prostatic metastasis
 Renal disease
 Hepatic metastatic infiltrations
 Obstructive jaundice
 Possibly following myocardial infarction

Taking these drugs may affect test results:
Aminoglycosides, Barbiturates, Clofibrate, Oral contraceptives, Pehnytoin

Other factors that may affect test results:
 Moderate intake of alcohol causes increased blood-GGT levels that may last for at least 60 hours.
 Failure to fast overnight
 If tourniquet is applied on the arm too long (over 1 minute), it may cause an inaccurate test result. Request another sample to be collected to ensure accuracy.

ISOCITRATE DEHYDROGENASE (ICD):
Purpose of the test:
 Provides important information to assess presence and extent of liver damage
 Detects early viral hepatitis and infectious mononucleosis
 Distinguishes between liver disease and myocardial infarction when SGOT is elevated

Normal values:
 Plasma-ammonia levels are less than 50mcg/dl

What "high" or "increased" may indicate:
 Bleeding from the gastrointestinal tract
 Congestive heart failure
 Erythroblastosis fetalis
 Reye's syndrome
 Sever liver disease leading to hepatic coma

Taking these drugs may affect test results:
Acetazolamide, Ammonium salts, Furosemide, Danamycin, Lactulose, Neomycin, Thiazides

Other factors that may affect test results:
 Portacaval shunt
 Hyperalimentation
 If tourniquet is applied on the arm too long (over 1 minute), it may cause an inaccurate test result. Request another sample to ensure accuracy.

PLASMA THROMBIN TIME (THROMBIN CLOTTING TIME):
Purpose of the test:
 Detects fibrinogen deficiency or defect
 Helps confirm diagnosis of DIC and liver disease
 Monitors effectiveness of heparin, streptokinase, or urokinase treatment

Normal values:
 Thrombin times range from 10 to 15 seconds. Test results are usually reported with a normal-control value.

What "high" or "increased" may indicate:
 Dysfibrinogenemia
 Effective heparin therapy
 Liver disease
 Hypofibrinogenemia
 If DIC is suspected, an additional test for fibrin split products is also necessary

Taking these drugs may affect test results:
Anti-coagulants, Heparin

Other factors that may affect test results:
If tourniquet is applied on the arm too long (over 1 minute), it may cause an inaccurate test result. Request another sample to be collected to ensure accuracy.

AST, ALT, GGTP, AP
 

What do these letters mean?
These letters are acronyms for enzymes - proteins inside of cells. AST for example stands for aspartate amino transferase. This enzyme used to be called serum glutamic oxalacetic transaminase (SGOT), hence the two names. ALT = amino alanine transferase, GGTP= gamma glutamyl transpeptidase, and AP= alkaline phosphatase. Different cells have different enzymes inside them, depending on the function of the cell. Liver cells happen to have lots of AST, ALT, and GGTP inside them. When cells die or are sick the enzymes leak out causing the blood level of these enzymes to rise, which is a way of determining if the cells in question are sick. ALT is more specific for liver disease than AST because AST is made in more places (e.g. heart, intestine, muscle). So the AST will rise after a heart attack or bruised kidney. GGTP and AP are said to be more specific for biliary disease since they are made in bile duct cells. In liver disease caused by excess alcohol ingestion, the AST tends to exceed the ALT, while the reverse is true to for viral hepatitis. However, this particular generalization is often wrong.

Some points:
•These tests have meaning, but they generally cannot be interpreted without clinical information. They are probably most useful to track, or follow a particular problem, but even then they often "bounce around" greatly.
•These numbers are not linear. An AST that is 300 is not twice as bad as 150 (normal is less than 50). We are used to numbers like temperature and dollars. If it is 94 degrees F outside, it is warmer than if it is 80 every time. And if one has 94 dollars, one has more money than if one has 80. Liver enzyme values don't behave this way. An AST of 94 and 80 are essentially the same to a liver specialist.
•These numbers do not always detect all liver disease. Some very patients with severe advanced liver disease will have normal or nearly normal enzyme levels.

Are these numbers indicative of liver function?
Not really. Unfortunately, they are often called "liver function tests" or "LFT's", but in actuality, they do not measure function per se.

Then how is liver function measured?
Other tests including albumin, bilirubin, and prothrombin time are more truly measures of function, but clinical factors must be considered as well.

BMJ 2004;328:987 (24 April), doi:10.1136/bmj.328.7446.987
Commentary

Liver function tests: defining what's normal

Paul Roderick, senior lecturer in public health1
1 Community Clinical Sciences Research Division, University of Southampton,
B Floor, South Academic Block, Southampton General Hospital, Southampton
SO16 6YD

Correspondence to: P Roderick pjr@soton.ac.uk

Chronic liver disease and hepatocellular carcinoma are major worldwide
public health problems in countries with endemically high levels of viral
hepatitis (B and C).1 However, even in western countries chronic liver
disease is an emerging problem, due not only to viral hepatitis but also to
the effects of lifestyle factors such as heavy alcohol consumption and
obesity.2 3

Liver function tests are widely performed blood tests used in patients with
suspected liver disease or unexplained illness and in some specific
situations such as screening of blood donors. The most widely used tests are
those used to detect the aminotransferases—alanine and aspartate—which are
associated with hepatocellular injury. Raised concentrations may indicate
serious underlying chronic liver disease, recognition of which is important
for guiding interventions to modify lifestyle and use of specific therapies
such as interferon for hepatitis C to prevent the risk of progression to
cirrhosis.

The sensitivity, specificity, and predictive values are important in
assessing the clinical utility of such tests. Normal ranges have been based
on distributions from healthy volunteers with two SD above the mean (that
is, top 2.5% cut-off) being considered the upper normal range.
Aminotransferase concentrations maybe within the normal range in people with
chronic liver disease.4 5 There is ongoing debate about whether to lower the
normal range to take account of changing lifestyle factors that influence
aminotransferase concentrations, particularly obesity, which in Western
countries would increase the detection of hepatitis C and alcoholic and
non-alcoholic fatty liver disease (NAFLD).6 7

Kim and colleagues have analysed the association between aminotransferase
concentrations and mortality from liver disease in a large prospective
cohort in Korea.1 They found that there was a graded increase in risk of
mortality from liver disease even within the normal range (20-40 IU/l)
compared with the lowest concentrations (< 20 IU/l) for both sexes. The
performance of the test in identifying future risk of mortality from liver
disease was maximised by lowering the threshold to about 30 IU/l. They
propose identifying a borderline level of aminotransferase of 30-39 IU/l,
suggesting that patients in this category should be further investigated
with more specific diagnostic tests for chronic liver disease.

What are the implications for countries with lower levels of chronic liver
disease than Korea? Test utility is affected by disease prevalence. In
countries with lower prevalence the negative predictive value (that is, the
ability of a negative test to exclude disease) will be higher and the
positive predictive value (that is, the ability of a positive test to
predict disease) will be lower. Lowering the upper normal range for
aminotransferase or including borderline cases will increase sensitivity at
the expense of specificity, so detecting more cases of chronic liver disease
but with a lower positive predictive value. These effects would be less
marked in those with suspected liver disease compared with the population as
whole. The cost effectiveness of further investigation of borderline cases
is not known but requires evaluation. A crucial diagnostic issue is how to
identify severe chronic liver disease (indicated by inflammation and
fibrosis), which is associated with high risk of progressing to cirrhosis.
Definitive evaluation currently relies on liver biopsy. Research is needed
to evaluate combinations of non-invasive measures to predict severe liver
disease; this could include patients with borderline concentrations of
aminotransferase.

--------------------------------------------------------------------------------
Competing interests: Research collaboration with Bayer Health-Care.
References

Kim HC, Nam CM, Jee SH, Han KH, Oh DY, Suh I. Normal serum aminotransferase
concentration and risk of mortality from liver disease: prospective cohort
study. BMJ 2004 doi/10.1136/bmj.38050.593634.63
Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated
aminotransferase levels in the United States. Am J Gastroenterol 2003;98:
960-7.[CrossRef][ISI][Medline]
Department of Health. On the state of the public health. The annual report
of the chief medical officer. London: Department of Health: 2002.
Kyrlagkitsis I, Portmann B, Smith H, O'Grady J, Cramp ME. Liver histology
and progression of fibrosis in individuals with chronic hepatitis C and
normal elevated ALT. Am J Gastroenterol 2003;98: 1588-93.[ISI][Medline]
Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in
asymptomatic patients. N Engl J Med 2000;342: 1266-71.[Free Full Text]
Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, del Vecchio E, et
al. Updated definitions of healthy ranges for serum alanine aminotransferase
levels. Ann Intern Med 2002;137: 1-9.[Abstract/Free Full Text]
Kaplan MM. Alanine transferase levels: what's normal. Ann Intern Med
2002;137: 49-50.[Free Full Text]
http://archive.mail-list.com/hbv_research/msg06625.html

 

 

 

 

  Page Two:

Overall view Of Liver Function Tests ( Long and Short Versions)

Hepatitis C Test Results

What does it all mean? (Interpreting Liver function tests)

TWO New Tests to detect Fibrosis ;

Prometheus Laboratories Introduces Non-Invasive Test for the Detection of Liver Fibrosis FIBROSpect

LabCorp® Announces U.S. Launch Of Exclusive Liver Fibrosis Assay HCV Fibrosure™

Found on our Biopsy Pages :

Scoring and Grading Liver Biopsies

Original HAI (Histology Activity Index), the Modified HAI, and the Metavir.